Strong association between serum hepatocyte growth factor and metabolic syndrome.

Hepatocyte growth factor (HGF) is one of the adipocytokines. We evaluated whether serum levels of HGF are related to the metabolic syndrome. A total of 1474 subjects of a general population free of liver, kidney, and lung diseases received a health examination.

Plasma endothelin-1 level is related to renal function and smoking status but not to blood pressure: an epidemiological study.

Objective: Endothelin-1 (ET-1) is a potent vasoconstrictor derived from the endothelium. Several studies with small numbers of humans have showed high plasma ET-1 levels in hypertension, but other studies have not. Furthermore, it has been shown in a small number of subjects that ET-1 is elevated in uraemic patients.

Serum lipoprotein(a) concentration and Apo(a) isoform under the condition of renal dysfunction.

A serum lipoprotein(a) (Lp(a)) is an independent risk factor for cardiac events. It is well known that the patients with chronic renal failure (CRF) have a high concentration of serum Lp(a). The purpose of this study was to indicate the relationship between serum Lp(a) concentration and apoprotein(a) (apo(a)) isoforms under the condition of renal dysfunction.

Plasma homocysteine levels and atherosclerosis in Japan: epidemiological study by use of carotid ultrasonography.

Background And Purpose: We examined whether hyperhomocysteinemia is an independent risk factor for increased carotid artery intimal-medial wall thickness (IMT) in a large, randomly selected community in Japan where the dietary habit is different and the incidence of coronary artery disease is lower compared with those of western countries.

Methods: In 1111 cases (452 men, 659 women) aged 63+/-10 years old (range, 40 to 94 years) recruited from a population-based survey performed in 1999, we measured fasting plasma total homocysteine levels and performed bilateral carotid B-mode ultrasound. The participants underwent measurements of other blood chemistries (total cholesterol, HDL cholesterol, glycosylated hemoglobin A(1c), and creatinine).

Interstitial pneumonia induced by ticlopidine.

A 67-year-old female non-smoker, who had been diagnosed with familial hypercholesterolemia associated with severe atherosclerosis of the coronary, carotid and vertebral arteries, developed interstitial pneumonia 4 months after initiating ticlopidine to inhibit platelet aggregation. The lymphocyte stimulation test by ticlopidine was positive and bronchoalveolar lavage fluid showed an increase in lymphocytes and a decrease in the CD4+/8+ ratio, suggesting potentially undesirable side effects of ticlopidine. Two months after ticlopidine therapy was discontinued and prednisolone therapy started, the interstitial pneumonia had almost completely resolved.